Kenneth McCall, published a paper in 2025 finding that compounded GLP-1s were linked to higher rates of adverse effects than non-compounded products between 2018 and 2024, including more abdominal pain, diarrhea, and nausea
Sample TB-500 Research Protocol An example of research dosage protocol for investigating the use of TB-500 nasal spray with a total dose of 5.6mg per week, followed by a maintenance dose of 2.8mg per day for 8 weeks, and a spray strength of 100mcg per spray, taken twice a day, could be structured as follows: Study Duration: The study duration will be 12 weeks, consisting of a 4-week initial treatment period followed by an 8-week maintenance phase
This selective action makes AOD 9604 particularly valuable for individuals seeking pure fat loss without the complex side effects associated with other weight loss interventions
Its primary area of research is in metabolic conditions, focusing on its potential effects on glucose regulation, appetite, and energy expenditure
